Stéphane Verdood s Managing Partner of Vesalius Biocapital Fund 1, Fund 2 and Fund 3 and Lead Partner for Apitope, FF Pharma, Genkyotex (reverse merger with Genticel, now Euronext-quoted), Genomic Vision (Euronext-quoted) and Trod Medical. He has over 26 years of experience in the life sciences industry. Stéphane was Founder and Managing Partner at Value4Growth, a specialized Life Science consulting firm, together with Gaston Matthyssens and Guy Geldhof. He i.a. founded and led Arthur Andersen's business consulting division in Belgium and Luxembourg and served on the European Board of Partners of Arthur Andersen. Stéphane has a MBA and a Master's degree in commercial engineering from the Catholic University of Leuven.